塞力医疗: 信达证券股份有限公司关于塞力斯医疗科技集团股份有限公司使用部分闲置募集资金临时补充流动资金的核查意见

Group 1 - The company has raised a total of RMB 543.31 million through the issuance of convertible bonds, with a net amount of RMB 533.30 million after deducting related fees [1] - As of May 31, 2025, the company has utilized RMB 20.19 million of the raised funds, achieving an overall investment progress of 37.90% [2] - The company plans to use up to RMB 325 million of idle raised funds temporarily to supplement working capital, ensuring it does not affect the progress of investment projects [3][5] Group 2 - The company has previously used idle funds amounting to RMB 90 million and RMB 390 million for temporary working capital, with specific repayment schedules outlined [3] - The supervisory board has approved the temporary use of idle funds, stating it will enhance fund efficiency and reduce financial costs without harming shareholder interests [5][6] - The sponsor institution has confirmed that the procedures followed for the use of idle funds comply with relevant regulations and do not alter the intended use of the raised funds [4][6]